These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12734926)

  • 1. Fluvoxamine therapy for fibromyalgia.
    Nishikai M; Akiya K
    J Rheumatol; 2003 May; 30(5):1124. PubMed ID: 12734926
    [No Abstract]   [Full Text] [Related]  

  • 2. A single dose of fluvoxamine associated with an acute psychotic reaction.
    Sim FH; Massabki RA
    Can J Psychiatry; 2000 Oct; 45(8):762. PubMed ID: 11086561
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibromyalgia remains a controversial medical enigma.
    Adams SM
    Am Fam Physician; 2008 May; 77(9):1222; author reply 1222, 1224. PubMed ID: 18540486
    [No Abstract]   [Full Text] [Related]  

  • 4. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N; Terao T; Ohmori O; Nakamura J
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluvoxamine-associated oscillopsia and a role for personalized medication dosing.
    Singman EL; Hocum B; Yohannan J; Pearson V
    Drug Metab Pers Ther; 2015 Dec; 30(4):271-5. PubMed ID: 26351962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe diurnal somnolence induced by fluvoxamine-lithium combination.
    Marchesi C; Paini M; Maggini C
    Pharmacopsychiatry; 2005 May; 38(3):145-6. PubMed ID: 15902588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluvoxamine and convulsive syncope: case report].
    Régina W; Vandel S
    Therapie; 1998; 53(5):504-5. PubMed ID: 9921046
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.
    Kamo T; Horikawa N; Tsuruta Y; Miyasita M; Hatakeyama H; Maebashi Y
    Psychiatry Clin Neurosci; 2004 Apr; 58(2):133-7. PubMed ID: 15009816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal medicine in the treatment of fluvoxamine-induced nausea and dyspepsia.
    Yamada K; Kanba S; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):681. PubMed ID: 10687751
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Ueda N; Nakamura J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):452. PubMed ID: 17610677
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients].
    Habrat B; Załoga B
    Psychiatr Pol; 2006; 40(3):579-97. PubMed ID: 17037821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluvoxamine and serotonin syndrome in a patient with Parkinson disease].
    Le Cavorzin P; Sarkis S; Bénéton C; Pinel JF; Maruelle L; Le Vaou P; Allain H
    Therapie; 1996; 51(2):195-6. PubMed ID: 8763057
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug interaction of tizanidine and fluvoxamine.
    Momo K; Doki K; Hosono H; Homma M; Kohda Y
    Clin Pharmacol Ther; 2004 Nov; 76(5):509-10. PubMed ID: 15536467
    [No Abstract]   [Full Text] [Related]  

  • 16. Navigating the co-prescription of clozapine and fluvoxamine.
    Shymko G; Clark V; Shymko L; Waters F
    Schizophr Res; 2018 Dec; 202():391-393. PubMed ID: 30269927
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis.
    Ke CL; Chen CC; Lin CT; Chen GS; Chai CY; Cheng ST
    J Am Acad Dermatol; 2006 Aug; 55(2):355-6. PubMed ID: 16844531
    [No Abstract]   [Full Text] [Related]  

  • 18. Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression.
    Fukui N; Suzuki Y; Sugai T; Watanabe J; Ono S; Tsuneyama N; Someya T
    Psychiatry Res; 2014 Aug; 218(3):353-5. PubMed ID: 24814141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
    Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
    J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.